Literature DB >> 30361244

Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.

David B Hill1,2, Robert F Long2, William J Kissner2, Eyad Atieh2, Ian C Garbarine2, Matthew R Markovetz2, Nicholas C Fontana2, Matthew Christy2, Mehdi Habibpour2, Robert Tarran2,3, M Gregory Forest4,5,6, Richard C Boucher2, Brian Button2,6,7.   

Abstract

Cystic fibrosis (CF) is a recessive genetic disease that is characterised by airway mucus plugging and reduced mucus clearance. There are currently alternative hypotheses that attempt to describe the abnormally viscous and elastic mucus that is a hallmark of CF airways disease, including: 1) loss of CF transmembrane regulator (CFTR)-dependent airway surface volume (water) secretion, producing mucus hyperconcentration-dependent increased viscosity, and 2) impaired bicarbonate secretion by CFTR, producing acidification of airway surfaces and increased mucus viscosity.A series of experiments was conducted to determine the contributions of mucus concentration versus pH to the rheological properties of airway mucus across length scales from the nanoscopic to macroscopic.For length scales greater than the nanoscopic, i.e. those relevant to mucociliary clearance, the effect of mucus concentration dominated over the effect of airway acidification.Mucus hydration and chemical reduction of disulfide bonds that connect mucin monomers are more promising therapeutic approaches than alkalisation.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30361244      PMCID: PMC6446239          DOI: 10.1183/13993003.01297-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  46 in total

1.  On the mechanics of mucociliary flows. III. Flow-velocity profiles in frog palate mucus.

Authors:  H Winet; G T Yates; T Y Wu; J Head
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-03

2.  Development of an airway mucus defect in the cystic fibrosis rat.

Authors:  Susan E Birket; Joy M Davis; Courtney M Fernandez; Katherine L Tuggle; Ashley M Oden; Kengyeh K Chu; Guillermo J Tearney; Michelle V Fanucchi; Eric J Sorscher; Steven M Rowe
Journal:  JCI Insight       Date:  2018-01-11

3.  Microstructural alterations of sputum in cystic fibrosis lung disease.

Authors:  Gregg A Duncan; James Jung; Andrea Joseph; Abigail L Thaxton; Natalie E West; Michael P Boyle; Justin Hanes; Jung Soo Suk
Journal:  JCI Insight       Date:  2016-11-03

4.  The in vitro effect of nebulised hypertonic saline on human bronchial epithelium.

Authors:  Jennifer L Goralski; Dan Wu; William R Thelin; Richard C Boucher; Brian Button
Journal:  Eur Respir J       Date:  2018-05-17       Impact factor: 16.671

5.  Human nasal and tracheo-bronchial respiratory epithelial cell culture.

Authors:  M Leslie Fulcher; Scott H Randell
Journal:  Methods Mol Biol       Date:  2013

Review 6.  New concepts of the pathogenesis of cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

Review 7.  Mucus structure and properties in cystic fibrosis.

Authors:  Bruce K Rubin
Journal:  Paediatr Respir Rev       Date:  2007-03-21       Impact factor: 2.726

8.  Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?

Authors:  Huw D Williams; Volker Behrends; Jacob G Bundy; Ben Ryall; James E A Zlosnik
Journal:  Front Microbiol       Date:  2010-11-11       Impact factor: 5.640

9.  Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.

Authors:  Alex Horsley; Karine Rousseau; Caroline Ridley; William Flight; Andrew Jones; Thomas A Waigh; David J Thornton
Journal:  J Cyst Fibros       Date:  2013-12-12       Impact factor: 5.482

10.  The buffer capacity of airway epithelial secretions.

Authors:  Dusik Kim; Jie Liao; John W Hanrahan
Journal:  Front Physiol       Date:  2014-06-03       Impact factor: 4.566

View more
  29 in total

1.  Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.

Authors:  Kathryn A Ramsey; Alice C H Chen; Giorgia Radicioni; Rohan Lourie; Megan Martin; Amy Broomfield; Yong H Sheng; Sumaira Z Hasnain; Graham Radford-Smith; Lisa A Simms; Lucy Burr; David J Thornton; Simon D Bowler; Stephanie Livengood; Agathe Ceppe; Michael R Knowles; Peadar G Noone; Scott H Donaldson; David B Hill; Camille Ehre; Brian Button; Neil E Alexis; Mehmet Kesimer; Richard C Boucher; Michael A McGuckin
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

2.  Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways.

Authors:  Yan Shin J Liao; Shin Ping Kuan; Maria V Guevara; Emily N Collins; Kalina R Atanasova; Joshua S Dadural; Kevin Vogt; Veronica Schurmann; Laura Bravo; Eda Eken; Mariana Sponchiado; Leah R Reznikov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

3.  Endotracheal tube mucus as a source of airway mucus for rheological study.

Authors:  Matthew R Markovetz; Durai B Subramani; William J Kissner; Cameron B Morrison; Ian C Garbarine; Andrew Ghio; Kathryn A Ramsey; Harendra Arora; Priya Kumar; David B Nix; Tadahiro Kumagai; Thomas M Krunkosky; Duncan C Krause; Giorgia Radicioni; Neil E Alexis; Mehmet Kesimer; Michael Tiemeyer; Richard C Boucher; Camille Ehre; David B Hill
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-07       Impact factor: 5.464

4.  Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.

Authors:  Kaitlyn R Rouillard; David B Hill; Mark H Schoenfisch
Journal:  J Cyst Fibros       Date:  2020-03-21       Impact factor: 5.482

Review 5.  Mucus, mucins, and cystic fibrosis.

Authors:  Cameron Bradley Morrison; Matthew Raymond Markovetz; Camille Ehre
Journal:  Pediatr Pulmonol       Date:  2019-11

6.  Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus Transport.

Authors:  Adegboyega Timothy Adewale; Emily Falk Libby; Lianwu Fu; Andrew Lenzie; Evan R Boitet; Susan E Birket; Courtney Fernandez Petty; J Dixon Johns; Marina Mazur; Guillermo J Tearney; Dan Copeland; Carolyn Durham; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

7.  Induction of ciliary orientation by matrix patterning and characterization of mucociliary transport.

Authors:  Patrick R Sears; Ximena M Bustamante-Marin; Henry Gong; Matthew R Markovetz; Richard Superfine; David B Hill; Lawrence E Ostrowski
Journal:  Biophys J       Date:  2021-03-09       Impact factor: 4.033

8.  Membrane-bound mucins of the airway mucosal surfaces are densely decorated with keratan sulfate: revisiting their role in the Lung's innate defense.

Authors:  Jerome Carpenter; Mehmet Kesimer
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

Review 9.  Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

Authors:  Michael C McKelvey; Ryan Brown; Sinéad Ryan; Marcus A Mall; Sinéad Weldon; Clifford C Taggart
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

10.  Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration.

Authors:  Cameron B Morrison; Kendall M Shaffer; Kenza C Araba; Matthew R Markovetz; Jason A Wykoff; Nancy L Quinney; Shuyu Hao; Martial F Delion; Alexis L Flen; Lisa C Morton; Jimmy Liao; David B Hill; Mitchell L Drumm; Wanda K O'Neal; Mehmet Kesimer; Martina Gentzsch; Camille Ehre
Journal:  Eur Respir J       Date:  2022-02-03       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.